Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK/PD”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03585322
What this trial is testing

APG-1387 Study of Safety, Tolerability ,PK/PD in Patients With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Ascentage Pharma Group Inc. 49
Testing effectiveness (Phase 2)Ended earlyNCT03330457
What this trial is testing

A Healthy Volunteer PK/PD, Safety and Tolerability Study of Andexanet After Betrixaban Dosing

Who this might be right for
Bleeding
Portola Pharmaceuticals 18
Early research (Phase 1)Study completedNCT04727138
What this trial is testing

3-part Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EXS21546

Who this might be right for
Oncology
Exscientia AI Limited 64
Early research (Phase 1)UnknownNCT03120273
What this trial is testing

A Clinical Trial to Evaluate the Safety and Tolerability of Dexlansoprazole Injection in Healthy Chinese Adults（Part 2）

Who this might be right for
Effect of DrugsSafety Issues
First Affiliated Hospital of Zhejiang University 70
Early research (Phase 1)Not Yet RecruitingNCT07406438
What this trial is testing

To Evaluate the Safety, Pharmacokinetics, and Efficacy of GB10 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
Shenzhen Kexing Pharmaceutical Co., Ltd. 48
Very early researchUnknownNCT03537482
What this trial is testing

APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
Ascentage Pharma Group Inc. 90
Testing effectiveness (Phase 2)Study completedNCT00322023
What this trial is testing

Safety and Effectiveness of D-serine in Schizophrenia

Who this might be right for
Schizophrenia
Nathan Kline Institute for Psychiatric Research 55
Testing effectiveness (Phase 2)Active Not RecruitingNCT07471880
What this trial is testing

A Phase II Trial of RAB001 (LLP2A-Alendronate) for Steroid-Induced Early-Stage Osteonecrosis of the Femoral Head

Who this might be right for
OsteonecrosisOsteonecrosis of the Femoral Head
ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd. 161
Testing effectiveness (Phase 2)Study completedNCT01407003
What this trial is testing

Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessment of LIK066 in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Novartis Pharmaceuticals 138
Early research (Phase 1)Ended earlyNCT06961370
What this trial is testing

Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Who this might be right for
Geographic AtrophyAge-related Macular Degeneration
Hoffmann-La Roche 27
Early research (Phase 1)Study completedNCT03282851
What this trial is testing

Pharmacokinetics/Pharmacodynamics (PK/PD) Equivalence Study of MSB11456

Who this might be right for
Healthy
Fresenius Kabi SwissBioSim GmbH 696
Testing effectiveness (Phase 2)WithdrawnNCT04025177
What this trial is testing

Indomethacin PK-PD in Extremely Preterm Neonates

Who this might be right for
Patent Ductus Arteriosus After Premature Birth
University of Manitoba
Testing effectiveness (Phase 2)Study completedNCT01965509
What this trial is testing

A PK/PD Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT06613477
What this trial is testing

PK/PD of Digoxin in Infants With SVHD

Who this might be right for
Single-ventricleInfant ConditionsInfant, Newborn, Diseases+1 more
Duke University 24
Early research (Phase 1)Study completedNCT01687205
What this trial is testing

Coital Pharmacokinetics/Pharmacodynamics (PK/PD) of Tenofovir Gel

Who this might be right for
Pharmacokinetics of 1% Tenofovir Gel Following CoitusPharmacodynamics of 1% Tenofovir Gel Following Coitus
CONRAD 31
Testing effectiveness (Phase 2)Study completedNCT00617994
What this trial is testing

Open Label, Safety and Efficacy Study of Topical Investigational Drug to Treat Patients With Psoriasis

Who this might be right for
Psoriasis
Incyte Corporation 25
Early research (Phase 1)UnknownNCT02366351
What this trial is testing

The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Type 2 Diabetes Mellitus Patients

Who this might be right for
Type 2 Diabetes Mellitus
Jiangsu HengRui Medicine Co., Ltd. 168
Early research (Phase 1)Study completedNCT06678581
What this trial is testing

SAD,MAD and Food Effect Study of SAP-001 Tablets in Chinese Subjects

Who this might be right for
GoutHyperuricemia
Shanton Pharma Co., Ltd. 70
Early research (Phase 1)Study completedNCT03762772
What this trial is testing

Safety, PK, and PD Study of a Vaginal Insert Containing TAF and EVG

Who this might be right for
HivHSV
CONRAD 16
Testing effectiveness (Phase 2)Study completedNCT01083732
What this trial is testing

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim 18
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation